This is a regulatory disclosure pursuant to Regulation 30 of the SEBI Listing Regulations regarding the outcome of the Board of Directors meeting held on November 12, 2026.

The Board meeting, which commenced at 07:00 p.m. and concluded at 07:30 p.m., approved the following matters related to the previously announced rights issue:

Rights Issue Details

The rights issue involves the issuance of partly paid-up equity shares of face value of ₹10 each for an amount not exceeding ₹90.00 crore.

Payment Schedule

  • On Application: ₹5.00 face value + ₹1.25 premium = ₹6.25 per share
  • First and Final Call: ₹5.00 face value + ₹1.25 premium = ₹6.25 per share
  • Total Payment: ₹10.00 face value + ₹2.50 premium = ₹12.50 per share

The first and final call payment period is scheduled from December 25, 2026 to December 31, 2026.

The Board retains the right to change the above schedule of payment, including the timing of the calls and the amount payable on each call, on account of business requirements and other commercial considerations, subject to compliance with applicable laws.

Rights Issue Timeline

  • Last date for credit of Rights Entitlements: November 19, 2026
  • Issue Opening Date: November 27, 2026
  • Last Date for on Market Renunciation of Rights Entitlements: December 02, 2026
  • Issue Closing Date: December 07, 2026

Eligible Equity Shareholders are requested to ensure that renunciation through off-market transfer is completed in such a manner that the Rights Entitlements are credited to the demat account of the Renouncees on or prior to the Issue Closing Date.

The Board or the Rights Issue Committee will have the right to extend the Issue Period as it may determine from time to time but not exceeding 30 days from the Issue Opening Date (inclusive of the Issue Opening Date). No withdrawal of Application shall be permitted by any Applicant after the Issue Closing Date.

Additional Approvals

The Board also approved the Letter of Offer to be filed with the Securities and Exchange Board of India and BSE Limited.

This disclosure follows previous intimations dated July 16, 2026 (initial Board approval) and November 12, 2026 (Rights Issue Committee approval of terms).